Home Cart Sign in  
Chemical Structure| 135558-11-1 Chemical Structure| 135558-11-1

Structure of Lobaplatin
CAS No.: 135558-11-1

Chemical Structure| 135558-11-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lobaplatin is a diastereometric mixture of platinum(II) complexes containing a 1,2-bis(aminomethyl)cyclobutane stable ligand and lactic acid as the leaving group. Its antitumour activity results from the formation of DNA-drug adducts, mainly as GG and AG intra-strand cross-links.

Synonyms: D-19466

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lobaplatin

CAS No. :135558-11-1
Formula : C9H18N2O3Pt
M.W : 397.33
SMILES Code : CC([O-]1)C([O-][Pt]21[NH2+]CC(CC3)C3C[NH2+]2)=O
Synonyms :
D-19466
MDL No. :MFCD00866545

Safety of Lobaplatin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Lobaplatin

DNA
pyroptosis

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03731442 Esophageal Cancer Phase 3 Recruiting October 31, 2027 China, Beijing ... More >> Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, Beijing, China, 100021 Contact: Zefen Xiao, MD Less <<
NCT03328234 IMRT With or Without Concurren... More >>t Chemotherapy for Esophageal Cancer Less << Phase 3 Recruiting December 31, 2022 China ... More >> Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, China, 100021 Contact: Xin Wang, MD    +861013311583220    beryl_wx2000@163.com Less <<
NCT03308552 Esophageal Neoplasms Phase 3 Recruiting August 30, 2021 China, Beijing ... More >> Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, Beijing, China, 100021 Contact: Zefen Xiao, MD Less <<
NCT02856126 Hepatocellular Carcinoma Phase 3 Recruiting August 2018 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT01229839 Hepatocellular Carcinoma Phase 3 Unknown August 2018 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD    86-2087343582 ext 86-2087343582    shiming@mail.sysu.edu.cn    Contact: Rong Ping Guo, MD    86-2087343117 ext 86-2087343117    guorongp@mail.sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT01259414 Hepatocellular Carcinoma Phase 3 Unknown January 2017 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Ming Shi    86-2087343582 ext 86-2087343582    shiming@mail.sysu.edu.cn    Contact: Ping Rong Guo    86-2087343117 ext 86-2087343117    guorongp@mail.sysu.edu.cn    Principal Investigator: Ming Shi Less <<
NCT02435953 Hepatocellular Carcinoma ... More >> Chemoembolization, Therapeutic Ablation Techniques, RFA Less << Phase 4 Recruiting - China, Guangdong ... More >> Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, doctor    +86 020 87343272    zhaoming@sysucc.org.cn    Contact: Tao Pan, doctor    +86 020 87343271    pantao0909@hotmail.com Less <<
NCT02973685 HepatoCellular Carcinoma Phase 3 Recruiting October 2019 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT03048123 Hepatocellular Carcinoma Phase 2 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT02430974 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown January 2018 -
NCT03196869 Locally Advanced Head and Neck... More >> Squamous Cell Carcinoma Less << Phase 2 Recruiting August 12, 2022 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Feng Jin, Bachelor    0851-86512802    jinf8865@yahoo.com.cn    Sub-Investigator: Weili Wu, master          Sub-Investigator: Jinhua Long, master          Sub-Investigator: Yuanyuan Li, master          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Xiaoxiao Chen, Bachelor          Sub-Investigator: Juan Li, Bachelor Less <<
NCT03349827 Peritoneal Metastases From Gas... More >>tric Cancer Less << Not Applicable Recruiting November 30, 2020 China, Hubei ... More >> Wuhan University Recruiting Wuhan, Hubei, China Contact: Bin Xiong    +86 27 67813152    jyn1983@163.com Less <<
NCT02301091 Hepatocellular Carcinoma Phase 3 Recruiting October 2019 China, Guangdong ... More >> Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, doctor    +86 020 87343272    zhaoming@sysucc.org.cn Less <<
NCT01869088 Hepatocellular Carcinoma Phase 3 Active, not recruiting January 2018 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China Less <<
NCT02678806 HepatoCellular Carcinoma Not Applicable Recruiting November 1, 2022 China, Guangxi ... More >> TaoBai Recruiting Nanning, Guangxi, China, 530000 Contact: Bai Tao, MD    +86 13878862632    25859373@qq.com Less <<
NCT02972320 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Unknown December 2018 China, Liaoning ... More >> The First Affiliated Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: mingfang zhao, professor    13644055129 Less <<
NCT03606239 Carcinoma, Non-Small-Cell Lung Not Applicable Not yet recruiting July 1, 2024 -
NCT00646100 Hepatocellular Carcinoma Phase 4 Completed - China, Guangdong ... More >> Cancer Canter Sun Yat-Sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT03413436 Esophageal Cancer Phase 4 Not yet recruiting February 21, 2018 China, Henan ... More >> Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university ZhengZhou, Henan, China, 450008 Less <<
NCT03221608 Colorectal Neoplasms Phase 3 Not yet recruiting August 1, 2024 -
NCT03371693 Ovarian Cancer ... More >> Ovary Neoplasm Ovarian Neoplasms Epithelial Ovarian Cancer Ovarian Cancer, Epithelial Hyperthermic Intraperitoneal Chemotherapy(HIPEC) Less << Phase 3 Active, not recruiting December 30, 2020 China, Hubei ... More >> Zhongnan Hospital of Wuhan University Wuhan, Hubei, China, 430072 Less <<
NCT01851746 - Unknown February 2015 China, Hubei ... More >> Zhongnan Hospital of Wuhan University Wuhan, Hubei, China, 430071 Less <<
NCT03117257 Locally Advanced Head and Neck... More >> Squamous Cell Carcinoma Less << Phase 2 Recruiting August 20, 2021 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Feng Jin, Bachelor    0851-86512802    jinf8865@yahoo.com.cn    Sub-Investigator: Weili Wu, master          Sub-Investigator: Jinhua Long, master          Sub-Investigator: Yuanyuan Li, master          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Xiaoxiao Chen, Bachelor          Sub-Investigator: Mang Zhang, Bachelor Less <<
NCT01034683 Esophageal Carcinoma Phase 3 Unknown December 2010 China, Shandong ... More >> Taian Cancer Hospital Taian, Shandong, China, 271000 Less <<
NCT03188497 Acute Toxic Effects ... More >> Tumor Responses Less << Phase 1 Completed - China, Guangdong ... More >> the Fifth Hospital Affiliated to Sun Yat-Sen University Zhuhai, Guangdong, China, 519000 Less <<
NCT03613753 Small-cell Lung Cancer Phase 2 Recruiting June 1, 2021 China, Guizhou ... More >> The affiliated hospital of Guizhou medical university Recruiting Guiyang, Guizhou, China, 550004 Contact: Shengfa Su, PhD,MD    86-13608550432    sushengfa2005@163.com Less <<
NCT01483300 Breast Cancer Phase 2 Unknown November 2014 China, Heilongjiang ... More >> Cancer Hospital of Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150081 Contact: Qingyuan Zhang, MD    86-451-86298276    zhma19650210@163.com    Contact: Xinmei Kang, MD    86-451-86298683    kxm791107@163.com    Principal Investigator: Qingyuan Zhang, MD          Sub-Investigator: Xinmei Kang, MD Less <<
NCT03613597 Small-cell Lung Cancer Phase 2 Recruiting January 1, 2022 China, Guizhou ... More >> The affiliated hospital of Guizhou medical university Recruiting Guiyang, Guizhou, China, 550004 Contact: Shengfa Su, PhD,MD    86-13608550432    sushengfa2005@163.com Less <<
NCT02099396 Lobaplatin and Gemcitabine in ... More >>Combination, Second-line Treatments on Advanced Osteosarcoma Less << Phase 2 Phase 3 Unknown - -
NCT03700359 Small Cell Lung Carcinoma Phase 2 Not yet recruiting November 29, 2021 -
NCT03210389 Recurrent Nasopharyngeal Carci... More >>noma Less << PHASE2 UNKNOWN 2025-12-21 Department of Radiation Oncolo... More >>gy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510000, China Less <<
NCT00493402 Hepatocellular Carcinoma Phase 3 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT01350206 Hepatocellular Carcinoma With ... More >>PVTT Less << Phase 4 Unknown May 2013 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Min-Shan Chen, M.D. Ph.D.    (8620) 8734 3117    Chminsh@mail.sysu.edu.cn    Principal Investigator: min-shan chen, M.D.,Ph.D. Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.52mL

0.50mL

0.25mL

12.58mL

2.52mL

1.26mL

25.17mL

5.03mL

2.52mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories